Markets · delayed Markets · delayed · loading…
Health desk · topic

Health

Every health story on Vozia, from every region — one page per story, both sides inside, every claim labelled.

A health worker in surgical scrubs and mask (illustrative)
Health AfricaHealth Checked story

Malaria vaccines are reaching more African children. What the numbers do — and don't — show yet

More countries are adding malaria vaccines to routine childhood immunisation. The rollout itself is documented. Claims about how much it has already cut deaths run ahead of the published data, and we have labelled them that way.

2 verified· 1 disputed· 1 not yet verified· 0 corrected
Your take
Sign in to record your take — it’s free, so one person counts once
Health AfricaHealth Checked story

The mpox emergencies are over — twice. The virus isn't

Two emergency declarations, two different end dates, one shared warning. The mpox story shows why 'the emergency is over' and 'the disease is over' are different sentences — and why Vozia labels them differently.

  • VerifiedThe WHO ended the mpox global health emergency on 5 September 2025.
  • VerifiedAfrica CDC kept its own continental emergency in place for months after the WHO lifted its, and ended it in January 2026.
  • DisputedEnding the emergency declarations means mpox is finished in Africa.
2 verified· 1 disputed· 0 not yet verified· 0 corrected
Your take
Sign in to record your take — it’s free, so one person counts once
Health AfricaBriefHealth Checked story

Two injections a year against HIV. The science is settled; the price is the story

A twice-yearly injection that prevented every infection in its main trial is the biggest HIV-prevention development in years. What the WHO has actually said is verified; whether the promised $40 price reaches African clinics is the part still to prove.

  • VerifiedIn July 2025 the WHO recommended twice-yearly injectable lenacapavir for HIV prevention.
  • VerifiedIn its main trial, the injection prevented every recorded HIV infection among more than 2,000 participants.
  • Not yet verifiedLenacapavir will be available at about $40 per person per year in African countries from 2027.
2 verified· 0 disputed· 1 not yet verified· 0 corrected
Your take
Sign in to record your take — it’s free, so one person counts once